Intrinsic Value of S&P & Nasdaq Contact Us

Syneos Health, Inc. SYNH NASDAQ

NASDAQ Global Select • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
67/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$72.00
+67.5%

Financial Health Score — SYNH

Syneos Health, Inc. (SYNH) has an overall financial health rating of A+ with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2023-09-29.

A+
Overall Rating
2023-09-29

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2023-09-29 A+ -/5 -/5 -/5 -/5 -/5 -/5
2023-09-27 A+ -/5 -/5 -/5 -/5 -/5 -/5
2023-09-26 A+ -/5 -/5 -/5 -/5 -/5 -/5
2023-09-25 A+ -/5 -/5 -/5 -/5 -/5 -/5
2023-09-22 A+ -/5 -/5 -/5 -/5 -/5 -/5
2023-09-21 A+ -/5 -/5 -/5 -/5 -/5 -/5
2023-09-20 A+ -/5 -/5 -/5 -/5 -/5 -/5
2023-09-19 A+ -/5 -/5 -/5 -/5 -/5 -/5
2023-09-18 A+ -/5 -/5 -/5 -/5 -/5 -/5
2023-09-15 A+ -/5 -/5 -/5 -/5 -/5 -/5
2023-09-14 A+ -/5 -/5 -/5 -/5 -/5 -/5
2023-09-13 A+ -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message